Nothing to cheer about Sun Pharma's FY20 guidance, says Research Delta Advisor

Nothing to cheer about Sun Pharma's FY20 guidance, says Research Delta Advisor

Nothing to cheer about Sun Pharma's FY20 guidance, says Research Delta Advisor

Nimish Mehta, founder and director of Research Delta Advisor shared his take on Sun Pharmaceutical Industries' earnings.

User: CNBC-TV18

Views: 2

Uploaded: 2019-05-29

Duration: 07:18

Your Page Title